HRH3 and neurodegenerative disease: Ligands with dual inhibitory activities on both H3R and HMT could increase intersynaptic histamine levels in the CNS and may lead to beneficial procognitive effects in psychiatric and neurodegenerative diseases (Apelt et al., 2002; Sander et al., 2008).